Literature DB >> 26254097

Regulation of activating protein-4-associated metastases of non-small cell lung cancer cells by miR-144.

Feng Gao1, Tao Wang, Zefeng Zhang, Rui Wang, Yang Guo, Junfeng Liu.   

Abstract

Activating protein-4 (AP4) has been recently shown to regulate the cancer metastases in some cancers including non-small cell lung cancer (NSCLC). Specifically, AP4 regulates mTor/p21 and transforming growth factor β (TGFβ) receptor signaling pathway to increase an epithelial-mesenchymal transition process to augment cell invasiveness. Nevertheless, how AP4 is regulated in NSCLC has not been studied. Here, we showed that in the specimens from the NSCLC patients, the levels of miR-144 were significantly decreased and the levels of AP4 were significantly increased, compared to the paired non-tumor lung tissue. The levels of miR-144 and AP4 inversely correlated in patients' specimens. Bioinformatics analyses revealed that miR-144 targeted the 3'-UTR of AP4 mRNA to inhibit its translation, confirmed by luciferase-reporter assay. Moreover, miR-144 overexpression inhibited AP4-mediated cell invasiveness, while miR-144 depletion increased AP4-mediated cell invasiveness in NSCLC cells. Together, our data suggest that miR-144 suppression may be the cause of the increased levels of AP4, as well as the augmented cancer metastases, in NSCLC.

Entities:  

Year:  2015        PMID: 26254097     DOI: 10.1007/s13277-015-3866-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

1.  p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.

Authors:  Lei Shi; Rene Jackstadt; Helge Siemens; Huihui Li; Thomas Kirchner; Heiko Hermeking
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

2.  Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer.

Authors:  Deping Zhao; Yi Lu; Chenlu Yang; Xiao Zhou; Zhifei Xu
Journal:  Tumour Biol       Date:  2015-01-08

3.  Vascular endothelial growth factor B coordinates metastasis of non-small cell lung cancer.

Authors:  Gang Liu; Shengbao Xu; Fanglei Jiao; Tao Ren; Qinchuan Li
Journal:  Tumour Biol       Date:  2014-11-26

4.  MiR-22 Suppresses BMP7 in the Development of Cirrhosis.

Authors:  Dong Ji; Bing Li; Qing Shao; Fan Li; Zhongbin Li; Guofeng Chen
Journal:  Cell Physiol Biochem       Date:  2015-06-16

5.  P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.

Authors:  Anna Goc; Ahmad Al-Azayzih; Maha Abdalla; Belal Al-Husein; Sravankumar Kavuri; Jeffrey Lee; Kelvin Moses; Payaningal R Somanath
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

6.  AP4 is required for mitogen- and c-MYC-induced cell cycle progression.

Authors:  Rene Jackstadt; Heiko Hermeking
Journal:  Oncotarget       Date:  2014-09-15

7.  MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.

Authors:  Qiang Wang; Jun Cai; Jingcheng Wang; Chuanzhi Xiong; Jianning Zhao
Journal:  Tumour Biol       Date:  2014-09-17

8.  Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation.

Authors:  N Bernardini; F Giannessi; F Bianchi; A Dolfi; M Lupetti; L Citti; R Danesi; M Del Tacca
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

9.  AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation.

Authors:  R Jackstadt; P Jung; H Hermeking
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

10.  Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo.

Authors:  Qiang Mei; Fang Li; Hongyu Quan; Yunlai Liu; Haidong Xu
Journal:  Cancer Sci       Date:  2014-07-03       Impact factor: 6.716

View more
  12 in total

1.  A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer.

Authors:  Danhua Qu; Bingdi Yan; Rui Xin; Tiangang Ma
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 2.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

3.  Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients.

Authors:  Yao Wu; Qing Yin; Ya-Ling Zhou; Lei He; Zhi-Qing Zou; Xiao-Yue Dai; Wen Xia
Journal:  Cancer Biol Ther       Date:  2021-02-04       Impact factor: 4.742

4.  MiR-144 promotes β-amyloid accumulation-induced cognitive impairments by targeting ADAM10 following traumatic brain injury.

Authors:  Liqian Sun; Manman Zhao; Jingbo Zhang; Aihua Liu; Wenjun Ji; Youxiang Li; Xinjian Yang; Zhongxue Wu
Journal:  Oncotarget       Date:  2017-07-22

5.  Pulmonary microRNA profiles identify involvement of Creb1 and Sec14l3 in bronchial epithelial changes in allergic asthma.

Authors:  Sabine Bartel; Nikola Schulz; Francesca Alessandrini; Andrea C Schamberger; Philipp Pagel; Fabian J Theis; Katrin Milger; Elfriede Noessner; Stephen M Stick; Anthony Kicic; Oliver Eickelberg; Robert J Freishtat; Susanne Krauss-Etschmann
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

6.  miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2.

Authors:  Lei Song; Liping Peng; Shucheng Hua; Xiaoping Li; Lianjun Ma; Jing Jie; Dong Chen; Ying Wang; Dan Li
Journal:  Biomed Res Int       Date:  2018-04-12       Impact factor: 3.411

7.  Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2.

Authors:  Yuan Liang; Dalin Zhang; Linlin Li; Tian Xin; Yuwei Zhao; Rui Ma; Jiang Du
Journal:  Stem Cell Res Ther       Date:  2020-02-26       Impact factor: 6.832

8.  Reduced miR-105-1 levels are associated with poor survival of patients with non-small cell lung cancer.

Authors:  Gaixia Lu; Da Fu; Chengyou Jia; Li Chai; Yang Han; Jin Liu; Tingmiao Wu; Ruting Xie; Zhengyan Chang; Huiqiong Yang; Pei Luo; Zhongwei Lv; Fei Yu; Xiaojun Zhong; Yushui Ma
Journal:  Oncol Lett       Date:  2017-10-19       Impact factor: 2.967

9.  AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin.

Authors:  Changhao Chen; Qingqing Cai; Wang He; Thomas B Lam; Jianxun Lin; Yue Zhao; Xu Chen; Peng Gu; Hao Huang; Miaoxin Xue; Hao Liu; Feng Su; Jian Huang; Jianping Zheng; Tianxin Lin
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

10.  Downregulated miR-144-3p contributes to progression of lung adenocarcinoma through elevating the expression of EZH2.

Authors:  Chao Liu; Zuozhang Yang; Zhiyong Deng; Youjun Zhou; Quan Gong; Ruilian Zhao; Ting Chen
Journal:  Cancer Med       Date:  2018-10-02       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.